One-third of NOAC patients treated inappropriately: study

One in three patients prescribed apixaban, dabigatran or rivaroxaban are not being treated according to evidence-based guidelines, a Brisbane study has found. Published in the Internal Medicine Journal the study concluded that 55 of 174 patients studied were treated inappropriately. Treatment with a NOAC was contraindicated in 40% of this group, mainly because of severe ...

Already a member?

Login to keep reading.

© 2021 the limbic